Profund Advisors Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$4.36M |
| 2 |
Super Micro Computer
SMCI
|
+$2.38M |
| 3 |
Moderna
MRNA
|
+$2.02M |
| 4 |
ConocoPhillips
COP
|
+$1.81M |
| 5 |
Berkshire Hathaway Class B
BRK.B
|
+$1.72M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$50.2M |
| 2 |
Microsoft
MSFT
|
+$20.1M |
| 3 |
Broadcom
AVGO
|
+$9.06M |
| 4 |
Meta Platforms (Facebook)
META
|
+$6.04M |
| 5 |
Amazon
AMZN
|
+$5.57M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 43.4% |
| 2 | Healthcare | 11.97% |
| 3 | Consumer Discretionary | 10.33% |
| 4 | Communication Services | 9.11% |
| 5 | Financials | 5.96% |
Similar funds
Profund Advisors's Q3 2024 Portfolio in Review
As of Q3 2024, Profund Advisors held 1,168 positions worth $2.64B, down 2% from $2.7B the previous quarter. Its ten largest holdings account for 37% of the portfolio.
Profund Advisors withdrew a net $136M in Q3 2024, closing 36 positions and reducing 555 holdings. Its most notable exit was Cerevel Therapeutics Holdings, Inc. Common Stock, an estimated $1.33M position sold in full.
By sector, the portfolio is most concentrated in Technology at 43% of assets, down from 47% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, Profund Advisors opened a new position in Palantir worth $1.57M.
- Profund Advisors's largest Q3 2024 buy was Palantir: 42,137 shares worth $1.57M.
- Profund Advisors added most to Apple in Q3 2024, an estimated $4.36M increase.
- Profund Advisors's biggest Q3 2024 reduction was NVIDIA, cutting an estimated $50.2M.
- Profund Advisors fully exited Cerevel Therapeutics Holdings, Inc. Common Stock in Q3 2024, selling an estimated $1.33M.
- Profund Advisors's ten largest holdings make up 37% of its $2.64B portfolio in Q3 2024.
- Profund Advisors opened 94 new positions and closed 36 in Q3 2024.
- Profund Advisors's portfolio value fell 2% quarter-over-quarter to $2.64B.
Based on Profund Advisors's 13F filing for Q3 2024, filed 14 Nov 2024.